Correlation Between Unicycive Therapeutics and NeuroSense Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and NeuroSense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and NeuroSense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and NeuroSense Therapeutics Ltd, you can compare the effects of market volatilities on Unicycive Therapeutics and NeuroSense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of NeuroSense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and NeuroSense Therapeutics.
Diversification Opportunities for Unicycive Therapeutics and NeuroSense Therapeutics
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Unicycive and NeuroSense is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and NeuroSense Therapeutics Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeuroSense Therapeutics and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with NeuroSense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeuroSense Therapeutics has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and NeuroSense Therapeutics go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and NeuroSense Therapeutics
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 3.44 times less return on investment than NeuroSense Therapeutics. But when comparing it to its historical volatility, Unicycive Therapeutics is 5.35 times less risky than NeuroSense Therapeutics. It trades about 0.24 of its potential returns per unit of risk. NeuroSense Therapeutics Ltd is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 15.00 in NeuroSense Therapeutics Ltd on September 12, 2024 and sell it today you would earn a total of 0.00 from holding NeuroSense Therapeutics Ltd or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 50.79% |
Values | Daily Returns |
Unicycive Therapeutics vs. NeuroSense Therapeutics Ltd
Performance |
Timeline |
Unicycive Therapeutics |
NeuroSense Therapeutics |
Unicycive Therapeutics and NeuroSense Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Unicycive Therapeutics and NeuroSense Therapeutics
The main advantage of trading using opposite Unicycive Therapeutics and NeuroSense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, NeuroSense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroSense Therapeutics will offset losses from the drop in NeuroSense Therapeutics' long position.Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
NeuroSense Therapeutics vs. Equillium | NeuroSense Therapeutics vs. DiaMedica Therapeutics | NeuroSense Therapeutics vs. Valneva SE ADR | NeuroSense Therapeutics vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |